Innovation Showcase Friday lunchtime

Innovation Showcase

Innovation Showcase: HUMAN PLURIPOTENT STEM CELL QUALITY: ESSENTIAL CONSIDERATIONS FOR GENE EDITING, CLONING, MAINTENANCE AND DISEASE MODELING - STEMCELL Technologies

6/22/2018
11:30 - 12:30

Human pluripotent stem cells (hPSCs) hold tremendous promise for a wide range of applications, including regenerative medicine, disease modeling, drug discovery and toxicology. Recently, there has been a dramatic increase in the generation of genome-edited hPSC lines due to widespread use of the CRISPR-Cas9 technology. As a result, researchers are becoming more aware of the critical importance of cell quality for generating robust and relevant data. This seminar will focus on how to maintain and assess high-quality hPSC cultures throughout the various stages of your research with an emphasis on five critical quality control aspects: genomic integrity, pluripotency, gene and marker expression, the epigenetic landscape and culture morphology. Speakers will also discuss the ArciTect™ family of products for ribonucleoprotein-based CRISPR-Cas9 genome editing, providing you with a rapid, flexible and precise protocol to modify the hPSC genome for various applications. Finally, methods to model neurological disease with cerebral organoids derived from high-quality hPSCs will be discussed.

Adam J. T. Hirst

Stemcell Technologies Inc, British Columbia, Canada

Presentation(s):

Send Email for Adam Hirst

Send Email for Vivian Lee


Assets

Innovation Showcase: HUMAN PLURIPOTENT STEM CELL QUALITY: ESSENTIAL CONSIDERATIONS FOR GENE EDITING, CLONING, MAINTENANCE AND DISEASE MODELING - STEMCELL Technologies



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Innovation Showcase: HUMAN PLURIPOTENT STEM CELL QUALITY: ESSENTIAL CONSIDERATIONS FOR GENE EDITING, CLONING, MAINTENANCE AND DISEASE MODELING - STEMCELL Technologies